Oridion Launches its Fully Integrated Remote Monitoring System and SARA Software for Improved Patient Safety

    JERUSALEM and NEEDHAM, MA, Oct. 15 /CNW/ - Oridion Systems Ltd. - (SWX:
ORIDN) is launching at this week's American Society of Anesthesiologists
Annual Meeting in San Francisco, CA its total solution Microstream(R)
Monitoring System (MSM(TM)), powered by the Bernoulli(R) Enterprise system.
The MSM system, a wireless technology for continuous central station
monitoring, is the only fully integrated ventilation and oxygenation remote
patient monitoring system that directly responded to the Anesthesia Patient
Safety Foundation (APSF) recommendation for improved Anesthesia Patient Safety
Foundation (APSF) recommendation for improved ventilation and oxygenation
monitoring for patients receiving patient controlled analgesia.
    Included in the 2006 APSF recommendations was the endorsement of remote
access to alarms, especially on the general floor environment where higher
patient-to-nurse ratios often do not allow on-going visual contact with the
patient as in other areas, such as the intensive care units and emergency
room. The MSM system helps improve patient safety because it instantaneously
alerts clinicians via wireless technology that a patient is in respiratory
    With the MSM system, clinicians have the benefit of closely monitoring
not just oxygenation status (oxygen carried in the blood), but also the
essential ventilation parameter - end-tidal carbon dioxide. Clinical studies
have demonstrated conclusively that carbon dioxide monitoring is the earliest
indication of a change in a patient's ventilation.
    The MSM powered by Bernoulli is the only central monitoring system that
supports the full range of Oridion capnography monitoring products, including
the Capnostream(TM) 20 and the patented Microstream FilterLine(R) sets for CO2
    Gerry Feldman, President of Oridion Capnography, Inc. said, "With this
system we have been able to deliver information about respiration and
ventilation that has never been experienced before. Its clinical impact is
seen on the faces of our customers who are able to report they can intervene
earlier and more accurately in crisis situations. This system, including the
new recently FDA approved SARA software (Smart Alarm Respiratory Analysis)
that safely reduces alarms by 55%, is the first responder to the
recommendations of the APSF."
    Oridion is the global leader of innovative capnography monitoring
solutions in the critical care, pain management, procedural sedation and
emergency medicine settings. The Oridion innovative Microstream technology
continues to be the industry gold standard for monitoring patient ventilation
in this broad range of clinical settings.
    The CPC Bernoulli Enterprise System offers state of the art software and
telemedicine solutions, which provide continuous, central, and remote,
real-time surveillance of the patient bedside from a plurality of medical
devices. Along with documenting, storing, and trending patient data, the
system offers instantaneous remote alarm notifications via centralized
monitoring and hand-held or paging systems.

    About Oridion
    Oridion Systems Ltd. (http://www.oridion.com) is a global medical device
company specializing in patient safety monitoring. The Company operates
through wholly owned subsidiaries in the United States, Europe, and Israel.
    Oridion develops proprietary medical devices and patient interfaces,
based on its patented Microstream(R) technologies, for the enhancement of
patient safety through the monitoring of the carbon dioxide (CO2) in a
patient's breath. These products provide effective, proven airway management
and are used in various clinical environments, including procedural sedation,
pain management, operating rooms, critical care units, post-anesthesia care
units, emergency medical services, transport, alternate care and other
settings where patients' ventilation may be compromised and at risk.

    About Cardiopulmonary Corporation
    Cardiopulmonary Corp. (CPC) located in Milford, CT, offers the
Bernoulli(R) Enterprise System software and telemedicine solutions, which
provide continuous, central, and remote, real-time surveillance of the patient
bedside from a plurality of medical devices. Bernoulli(R) uses web-based and
state of the art wired or wireless network technology to interface with
medical devices that have RS-232, Ethernet, or nurse call data interfaces.
Bernoulli(R) documents and stores routine status checks, which are mandated on
patient monitors, ventilators, and other medical devices, by the Joint
Commission of Healthcare Organizations (JCAHO), thus reducing the time
clinicians typically spend on documentation and improving the accuracy of the
reporting through the elimination of transcribing errors. Instantaneous
central station monitoring, and hand-held devices or pager notifications, of
patient alarms, settings, and patient values allow quick management of alarm
conditions. The system also trends patient data, increasing the accuracy of
patient assessment.

    Certain statements made herein that are not historical are
forward-looking within the meaning of the Private Securities Litigation Reform
Act of 1995. The words "estimate" "project" "intend" "expect" "believe" and
similar expressions are intended to identify forward-looking statements. These
forward-looking statements involve known and unknown risks and uncertainties.
Many factors could cause the actual results, performance or achievements of
the Company to be materially different from any future results, performance or
achievements that may be expressed or implied by such forward-looking
statements, including, among others, our ability to maintain profits, the
market demands for our Capnography products, our ability to focus our team on
the Capnography business, changes in general economic and business conditions,
inability to maintain market acceptance to the Company's products, inability
to timely develop and introduce new technologies, products and applications,
rapid changes in the market for the Company's products, loss of market share
and pressure on prices resulting from competition, introduction of competing
products by other companies, inability to manage growth and expansion, loss of
key OEM partners, inability to attract and retain qualified personnel,
inability to protect the Company's proprietary technology.
    Furthermore, this press release does not constitute an offer to sell or a
solicitation of an offer to buy any securities. The Company's shares issued
have not been, and will not be, registered under the US Securities Act of
1933, as amended (the "Securities Act"), or under any of the relevant
Securities Laws of any state of the United States. The Company's shares may
not be offered, sold or delivered, directly or indirectly, to, or for, the
account of any US person (as defined in regulation S under the Securities Act)
in or into the United States, or by use of the US mail, or by any means or
instrumentality of United States interstate commerce, absent registration, or
an exemption from registration under the Securities Act.

For further information:

For further information: Gerry Feldman, President; Walter Tabachnik,
Chief Financial Officer; Elena Gerberg, Investor Relations; (Israel) phone
+972-2-589-9159; Frank Justin, Director of Marketing (US) (781) 354-8073;
e-mail investor@oridion.com; address: Oridion Systems Ltd., P.O. Box 45025,
91450 Jerusalem, Israel

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890